miRNA let-7b inhibitors by treatment of diabetic retinopathy: evaluation patent US2019093106

Simple item page
dc.contributor.authorPérez-Santos, Martín
dc.date.accessioned2020-11-27T18:24:59Z
dc.date.available2020-11-27T18:24:59Z
dc.date.issued2020-05-21
dc.description.abstractIntroduction: diabetic retinopathy is a clinical complication that affects to a 93 million people suffering from diabetes and is responsible for more hospitalizations than any other complication of diabetes. Authors of US2019093106 patent propose a method for treatment of diabetic retinopathy. Areas covered: US2019093106 describes a method that consists of the administration of inhibitor of miRNA let-7b, in patients with diabetic retinopathy; additionally describe a method to inhibiting the effects of increased levels or activity of miRNA let-7b. Expert opinion: The results pre-clinical trials support the therapy’s efficacy; however, the invention is not new considering art state, whereby, new studies will be necessary to determine other administration routes, e.g. topical, dose and time of administration.es_MX
dc.identificatorAyTBUAP 5(18):1-7es_MX
dc.identifier.citationPérez-Santos M. miRNA let-7b inhibitors by treatment of diabetic retinopathy: evaluation patent US2019093106. Alianzas y Tendencias BUAP [Internet]. 2020;5(18):1–7. Available from: https://www.aytbuap.mx/publicaciones#h.n833pt4qitm3es_MX
dc.identifier.issn2594-0627
dc.identifier.other2594-0627
dc.identifier.otherhttps://www.aytbuap.mx/aytbuap-518/mirna-let-7b-inhibitors-by-treatment-of-diabetic-retinopathy
dc.identifier.urihttps://hdl.handle.net/20.500.12371/9407
dc.language.isoenges_MX
dc.publisherBenemérita Universidad Autónoma de Pueblaes_MX
dc.relation.ispartofseriesVolumen 5;Número 18
dc.subjectmiRNA let-7bes_MX
dc.subjectdiabetic retinopathyes_MX
dc.subjectpatentes_MX
dc.subjectdiabeteses_MX
dc.subjectinhibitores_MX
dc.titlemiRNA let-7b inhibitors by treatment of diabetic retinopathy: evaluation patent US2019093106es_MX
dc.typeArtículoes_MX
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
3 miRNA let-7b inhibitors by treatment of diabetic retinopathy evaluation patent US2019093106.pdf
Size:
455.7 KB
Format:
Adobe Portable Document Format
Description:
AyTBUA 5(18):1-7
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Revista Alianzas y Tendencias BUAP (AyTBUAP)